Publications by authors named "Po Ting Lin"

Claim this Profile
P
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.
Yuan-Hung Kuo, Wei Teng, Po-Ting Lin, Yen-Hao Chen, Chung-Wei Su, Shi-Ming Lin, Chen-Chun Lin, Chun-Yen Lin

Liver Int· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study.
Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Yi-Chung Hsieh, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

J Cancer Res Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic endocrine benefits of benign prostatic obstruction surgery.
Po-Ting Lin, Chien-Lun Chen, Yu-Hsiang Lin

World J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing".
Yu-Hsiang Lin, Kuo-Jen Lin, Po-Ting Lin

Sports Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Revisiting FOXP3 expression and its prognostic implications in hepatocellular carcinoma.
Chien-Hao Huang, Wei-Ting Ku, Tsung-Han Wu, Po-Ting Lin, Wei Teng, Chen-Chun Lin, Shi-Ming Lin, Yung-Chang Lin, Chun-Yen Lin

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly-accurate prediction of colorectal cancer through low abundance uncultivated genomes recovered using metagenomic co-assembly and binning approach.
Po-Ting Lin, Yu-Wei Wu

BMC Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab.
Tai-Chi Wu, Po-Ting Lin, Wei Teng, Eric Yi-Liang Shen, Chung-Wei Su, Chen-Chun Lin, Shi-Ming Lin, Chun-Yen Lin

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC.
Chien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng-Heng Wu, Tsung-Han Wu, Po-Ting Lin, Chen-Chun Lin, Shi-Ming Lin, Yung-Chang Lin, Chun-Yen Lin

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication.
Wei Teng, Wei-Ting Ku, Po-Ting Lin, Guan-Ting Chen, LiChieh Julie Chu, Yung-Chang Lin, Chun-Yen Lin

J Transl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: Computerized metric assessment of glandular tissue volume within the peripheral zone of the prostate using combined magnetic resonance imaging and histopathology: Possible pathophysiological implications on prostate cancer development.
Kuo-Jen Lin, Po-Ting Lin, Yu-Hsiang Lin

Investig Clin Urol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenteric pneumatosis on CT: a predictor of benign pneumatosis intestinalis.
Po-Jui Lu, Rheun-Chuan Lee, Nai-Chi Chiu, Po-Ting Lin, Chien-An Liu

Abdom Radiol (NY)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor size larger than 6.5 cm and microvascular invasion are comparable prognosticators for hepatocellular carcinoma: a multi-institutional observational study.
Hsing-Yu Chen, Hsin-I Tsai, Ming-Chin Yu, Wei-Chen Lee, Chih-Chi Wang, Po-Ting Lin

Clin Transl Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients.
Chung-Wei Liu, Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

J Hepatocell Carcinoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dysfunction as the missing link between circadian syndrome and dementia.
Yu-Hsiang Lin, Kuo-Jen Lin, Po-Ting Lin

J Prev Alzheimers Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.
Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Po-Ting Lin, Shi-Ming Lin

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid lightsheet fluorescence imaging of whole Drosophila brains at nanoscale resolution by potassium acrylate-based expansion microscopy.
Xuejiao Tian, Tzu-Yang Lin, Po-Ting Lin, Min-Ju Tsai, Hsin Chen, Suewei Lin, Peilin Chen

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design Optimization of a 3D Microfluidic Channel System for Biomedical Applications.
Radita Tyas Atsani Susanto, Brijesh Patel, Yu-Sheng Hsiao, Hsiu-Yang Tseng, Po Ting Lin

3D Print Addit Manuf· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Architecture for Predictive Monitoring of Unbalance Faults in a Turbine Rotor-Bearing System.
Banalata Bera, Shyh-Chin Huang, Po Ting Lin, Yu-Jen Chiu, Jin-Wei Liang

Sensors (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression.
Tsung-Hao Liu, San-Chi Chen, Kun-Ming Rau, Li-Chun Lu, Po-Ting Lin, Shi-Ming Lin

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
Yu-Chun Hsu, Po-Ting Lin, Wei Teng, Yi-Chung Hsieh, Wei-Ting Chen, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian Rhythms in Urology: Bridging Benign Prostatic Hyperplasia and Cardiovascular Disease Risk.
Yu-Hsiang Lin, Po Ting Lin, Kuo Jen Lin

Circ J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment.
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

J Formos Med Assoc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.
Chung-Wei Su, Wei Teng, Eric Yi-Liang Shen, Bing-Shen Huang, Po-Ting Lin, Chun-Yen Lin, Shi-Ming Lin, Chen-Chun Lin

Oncologist· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study.
Chao-Wei Lee, Hsing-Yu Chen, Ping-Han Tsai, Wei-Chen Lee, Chih-Chi Wang, Po-Ting Lin

J Cancer Res Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor.
Po-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, Wei Teng, Yi-Chung Hsieh, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

Am J Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis